| Financial Year |
March 31 2023 |
| Monetary Funds |
488,537,869.85 |
| Held-for-trading Financial Assets |
69,600,000.00 |
| Notes Receivable |
70,197,870.26 |
| Accounts Receivable |
769,075,138.17 |
| Advances to Suppliers |
44,499,698.80 |
| Other Receivables |
34,869,332.14 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
17,851,470.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,001,369.59 |
| Total Current Assets |
2,429,642,616.72 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
214,051,801.37 |
| Investment Properties |
-- |
| Fixed Assetes |
132,572,317.14 |
| Under-construction Projects |
208,719,552.53 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
165,603,760.72 |
| R&D expenses |
-- |
| Goodwill |
266,680,915.98 |
| Long-Term Deferred and Prepaid Expenses |
4,892,004.79 |
| Deferred Income Tax Assets |
50,277,173.48 |
| Other Non-Current Assets |
100,999.89 |
| Sub-Total of Non-Current Assets |
1,070,328,489.71 |
| Total Assets |
3,499,971,106.43 |
| Short-Term Loans |
388,619,929.76 |
| Trading Financial liabilities |
-- |
| Notes Payable |
12,137,687.00 |
| Accounts Payable |
857,771,085.94 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,125,860.06 |
| Taxes Payable |
48,442,843.51 |
| Interest Payable |
-1,752,568.41 |
| Dividend Payable |
2,450,000.00 |
| Other payables |
26,131,189.39 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,399,893.44 |
| Other Current Liabilities |
33,244,367.32 |
| Sub-Total of Current Liabilities |
1,697,647,975.02 |
| Long-term Loans |
122,030,246.59 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
651,426.33 |
| Deferred Income Tax Liabilities |
8,081,145.18 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
165,707,090.70 |
| Total Liabilities |
1,863,355,065.72 |
| Paid-In Capital(Or Share Stock) |
173,974,869.00 |
| Capital Surplus |
726,371,752.81 |
| Surplus Reserve |
81,109,109.97 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
603,101,019.08 |
| Minority Stockholder's Interest |
52,059,289.85 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,584,556,750.86 |
| Owner's Equity（Stockholder's Equity） |
1,636,616,040.71 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,499,971,106.43 |
